Liver transplantation for pediatric patients with congenital heart disease: A single‐center study in mainland China
Pediatric Transplantation · 2024
DOI: 10.1111/petr.14598 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Tingting Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The First Central Clinical School, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Diseases, End Stage Liver Disease, Heart Defects, Congenital. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin City, Tianjin Key Medical Discipline (Specialty) Construction Project.
Abstract (Originalsprache)
Background
Liver transplantation (LT) is a serious cardiovascular stressor for patients with end‐stage liver disease (ESLD). Data on the effects of cardiovascular diseases on pediatric LT is limited. No study on LT for pediatric patients with ESLD combined with congenital heart disease (CHD) has been reported from mainland China.
Methods
A total of 1005 patients were included in this study. The Kaplan–Meier method with log‐rank testing was used to evaluate survival outcomes between groups. Univariable and multivariable Cox regression models were used to determine the risk factors for patient and graft survival.
Results
The most common indication for LT was biliary atresia (BA 90.3%). The prevalence of CHD was 3.8% (38). 42 CHD were found in 38 patients. The incidence of death and graft loss was more common in the CHD group than in the no‐CHD group (13.2% vs. 5.0%, p = .045 and 15.8% vs. 6.2%, p = .019, respectively). The 5‐year patient survival and graft survival in the CHD group versus the no‐CHD group was 86.8% versus 94.7% (log‐rank p = .022) and 84.2% versus 93.5% (log‐rank p = .015), respectively. No significant differences were observed in re‐transplantation, hepatic artery thrombosis (HAT), and portal vein thrombosis (PVT). After adjusting for age, BMI, etiology of LT, and other confounding factors, we can still find that the presence of CHD was associated with patient and graft survival after LT.
Conclusion
The presence of CHD was associated with higher mortality and lower graft survival after LT. If possible, the cardiac defects should be addressed prior to LT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Central Clinical School, Tianjin Medical University, Tianjin, China.
- Department of Respiratory and Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Pediatric Transplant Department, Tianjin First Central Hospital, Tianjin, China.
- The Key Subject of Tianjin First Central Hospital, Tianjin, China.
- Ultrasound Department, Tianjin First Central Hospital, Tianjin, China.
- Department of Cardiology, Tianjin First Central Hospital, Tianjin, China.
ORCID-Profile: Tingting Li, Zhuqing Li, Qi Li, Chengzhi Lu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Tianjin City
- Tianjin Key Medical Discipline (Specialty) Construction Project
Zitieren
APA
Li, T., Wei, X., Hu, X., Ye, X., Li, C., Li, Z., Li, Q., Liu, C., Gao, W., & Lu, C. (2024). Liver transplantation for pediatric patients with congenital heart disease: A single‐center study in mainland China. Pediatric Transplantation. https://doi.org/10.1111/petr.14598
Vancouver
Li T, Wei X, Hu X, Ye X, Li C, Li Z, et al. Liver transplantation for pediatric patients with congenital heart disease: A single‐center study in mainland China. Pediatric Transplantation. 2024. doi:10.1111/petr.14598
BibTeX
@article{Li2024,
author = {Li, Tingting and Wei, Xinzhe and Hu, Xiangyu and Ye, Xuying and Li, Chao and Li, Zhuqing and Li, Qi and Liu, Chunlei and Gao, Wei and Lu, Chengzhi},
title = {Liver transplantation for pediatric patients with congenital heart disease: A single‐center study in mainland China},
journal = {Pediatric Transplantation},
year = {2024},
doi = {10.1111/petr.14598}
}
EUVIMED